BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 33915754)

  • 1. Insoluble Vascular Amyloid Deposits Trigger Disruption of the Neurovascular Unit in Alzheimer's Disease Brains.
    Soto-Rojas LO; Campa-Córdoba BB; Harrington CR; Salas-Casas A; Hernandes-Alejandro M; Villanueva-Fierro I; Bravo-Muñoz M; Garcés-Ramírez L; De La Cruz-López F; Ontiveros-Torres MÁ; Gevorkian G; Pacheco-Herrero M; Luna-Muñoz J
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33915754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Neurovascular Unit Dysfunction in Alzheimer's Disease.
    Soto-Rojas LO; Pacheco-Herrero M; Martínez-Gómez PA; Campa-Córdoba BB; Apátiga-Pérez R; Villegas-Rojas MM; Harrington CR; de la Cruz F; Garcés-Ramírez L; Luna-Muñoz J
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurovascular dysfunction and vascular amyloid accumulation as early events in Alzheimer's disease.
    Apátiga-Pérez R; Soto-Rojas LO; Campa-Córdoba BB; Luna-Viramontes NI; Cuevas E; Villanueva-Fierro I; Ontiveros-Torres MA; Bravo-Muñoz M; Flores-Rodríguez P; Garcés-Ramirez L; de la Cruz F; Montiel-Sosa JF; Pacheco-Herrero M; Luna-Muñoz J
    Metab Brain Dis; 2022 Jan; 37(1):39-50. PubMed ID: 34406560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct changes in all major components of the neurovascular unit across different neuropathological stages of Alzheimer's disease.
    Kirabali T; Rust R; Rigotti S; Siccoli A; Nitsch RM; Kulic L
    Brain Pathol; 2020 Nov; 30(6):1056-1070. PubMed ID: 32866303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.
    Bell RD; Zlokovic BV
    Acta Neuropathol; 2009 Jul; 118(1):103-13. PubMed ID: 19319544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer's disease brain.
    Ryu JK; McLarnon JG
    J Cell Mol Med; 2009 Sep; 13(9A):2911-25. PubMed ID: 18657226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Voluntary Physical Exercise on the Neurovascular Unit in a Mouse Model of Alzheimer's Disease.
    Andrade-Guerrero J; Orta-Salazar E; Salinas-Lara C; Sánchez-Garibay C; Rodríguez-Hernández LD; Vargas-Rodríguez I; Barron-Leon N; Ledesma-Alonso C; Diaz-Cintra S; Soto-Rojas LO
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct deposition of amyloid-β species in brains with Alzheimer's disease pathology visualized with MALDI imaging mass spectrometry.
    Kakuda N; Miyasaka T; Iwasaki N; Nirasawa T; Wada-Kakuda S; Takahashi-Fujigasaki J; Murayama S; Ihara Y; Ikegawa M
    Acta Neuropathol Commun; 2017 Oct; 5(1):73. PubMed ID: 29037261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid Beta-Mediated Neurovascular Toxicity in Alzheimer's Disease.
    Banerjee S; Banerjee S
    Methods Mol Biol; 2024; 2761():355-372. PubMed ID: 38427250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease.
    Yamazaki Y; Kanekiyo T
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of perivascular innervation and neurally mediated vasoreactivity in the pathophysiology of Alzheimer's disease.
    Nizari S; Romero IA; Hawkes CA
    Clin Sci (Lond); 2017 Jun; 131(12):1207-1214. PubMed ID: 28566449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's disease.
    Sweeney MD; Sagare AP; Zlokovic BV
    J Cereb Blood Flow Metab; 2015 Jul; 35(7):1055-68. PubMed ID: 25899298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood-brain barrier dysfunction underlying Alzheimer's disease is induced by an SSAO/VAP-1-dependent cerebrovascular activation with enhanced Aβ deposition.
    Solé M; Esteban-Lopez M; Taltavull B; Fábregas C; Fadó R; Casals N; Rodríguez-Álvarez J; Miñano-Molina AJ; Unzeta M
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2189-2202. PubMed ID: 31047972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of N-terminally truncated pyroglutamate amyloid-β in cholesterol-enriched diet-fed rabbit and AD brain.
    Perez-Garmendia R; Hernandez-Zimbron LF; Morales MA; Luna-Muñoz J; Mena R; Nava-Catorce M; Acero G; Vasilevko V; Viramontes-Pintos A; Cribbs DH; Gevorkian G
    J Alzheimers Dis; 2014; 39(2):441-55. PubMed ID: 24240639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurovascular Specifications in the Alzheimer-Like Brain of Mice Affected by Focal Cerebral Ischemia: Implications for Future Therapies.
    Michalski D; Hofmann S; Pitsch R; Grosche J; Härtig W
    J Alzheimers Dis; 2017; 59(2):655-674. PubMed ID: 28671120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's amyloid β heterogeneous species differentially affect brain endothelial cell viability, blood-brain barrier integrity, and angiogenesis.
    Parodi-Rullán R; Ghiso J; Cabrera E; Rostagno A; Fossati S
    Aging Cell; 2020 Nov; 19(11):e13258. PubMed ID: 33155752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different curcumin forms selectively bind fibrillar amyloid beta in post mortem Alzheimer's disease brains: Implications for in-vivo diagnostics.
    den Haan J; Morrema THJ; Rozemuller AJ; Bouwman FH; Hoozemans JJM
    Acta Neuropathol Commun; 2018 Aug; 6(1):75. PubMed ID: 30092839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer's disease.
    Thal DR; Walter J; Saido TC; Fändrich M
    Acta Neuropathol; 2015 Feb; 129(2):167-82. PubMed ID: 25534025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissecting the Contribution of Vascular Alterations and Aging to Alzheimer's Disease.
    Janota C; Lemere CA; Brito MA
    Mol Neurobiol; 2016 Aug; 53(6):3793-3811. PubMed ID: 26143259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.